Company Filing History:
Years Active: 2015-2020
Title: Claudia Wall: Innovator in Immunotherapy
Introduction
Claudia Wall is a prominent inventor based in Bruehl, Germany. She has made significant contributions to the field of immunotherapy, particularly through her innovative binding proteins. With a total of 3 patents, her work is paving the way for advancements in cancer treatment.
Latest Patents
One of her latest patents involves bispecific CD33 and CD3 binding proteins. These binding proteins are designed to specifically target human CD33, which is crucial for developing therapies for conditions such as acute myeloid leukemia (AML). The patent describes bispecific tandem diabodies that bind to CD33, highlighting their potential use in immunotherapy for various cancers and diseases.
Career Highlights
Claudia Wall is currently associated with Amphivena Therapeutics, Inc., where she continues to push the boundaries of medical research. Her work focuses on creating innovative solutions that can significantly impact patient care and treatment outcomes.
Collaborations
Throughout her career, Claudia has collaborated with notable colleagues, including Kristina Ellwanger and Luke Evnin. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking therapies.
Conclusion
Claudia Wall's contributions to immunotherapy through her innovative patents and collaborations are noteworthy. Her work exemplifies the impact of dedicated inventors in the medical field, and her ongoing research promises to bring new hope to patients battling cancer.